Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations

期刊论文
出版模式：

开放获取
发表日期：

2025年5月14日

查看全文

Carlos Jimenez-Vicente,
Aina Cardus,
Sandra Castaño-Diez,
Guillermo Ramil,
Sara Garcia-Avila,
Lucia Gomez-Perez,
Daniel Esteban,
Iago Arribas,
Antonella Lucia Sturla,
Monica Lopez-Guerra,
Alexandra Martinez-Roca,
Albert Cortes-Bullich,
Amanda Isabel Perez-Valencia,
Ines Zugasti,
Ines Monge,
Esther Carcelero,
Ferran Vall-Llovera,
Susana Vives,
Jorge Sierra,
Josep Nomdedeu,
Guadalupe Oñate,
Ana Garrido,
Marta Pratcorona,
Helena Pomares,
Montserrat Arnan,
Francesca Guijarro,
Marina Diaz-Beya,
Jordi Esteve

本文未提供摘要，请点击“查看全文”查看完整内容。